Function and design of the Nox1 system in vascular smooth muscle cells

BMC Systems Biology

Volumn 7, Issue , 2013, Pages

  Yin, Weiwei ^a   Voit, Eberhard O ^a  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NOX1 PROTEIN, HUMAN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ARTICLE; BIOLOGICAL MODEL; BIOLOGY; CYTOLOGY; HUMAN; METABOLISM; METHODOLOGY; MOLECULAR DYNAMICS; MONTE CARLO METHOD; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

COMPUTATIONAL BIOLOGY; HUMANS; MODELS, BIOLOGICAL; MOLECULAR DYNAMICS SIMULATION; MONTE CARLO METHOD; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NADPH OXIDASE;

MLCS; MLOWN;

EID: 84874795723     PISSN: None     EISSN: 17520509     Source Type: Journal    
DOI: 10.1186/1752-0509-7-20     Document Type: Article

References (62)

1. Griendling KK, Ushio-Fukai M. Reactive oxygen species as mediators of angiotensin II signaling. Regul Pept 2000, 91:21-27. 10.1016/S0167-0115(00)00136-1, 10967199.
2. Rhee SG. Redox signaling: hydrogen peroxide as intracellular messenger. Exp Mol Med 1999, 31:53-59. 10.1038/emm.1999.9, 10410302.
3. Touyz RM, Schiffrin EL. Reactive oxygen species in vascular biology: implications in hypertension. Histochem Cell Biol 2004, 122:339-352. 10.1007/s00418-004-0696-7, 15338229.
4. Guzik TJ, West NE, Black E, McDonald D, Ratnatunga C, Pillai R, Channon KM. Vascular superoxide production by NAD(P)H oxidase: association with endothelial dysfunction and clinical risk factors. Circ Res 2000, 86:E85-E90. 10.1161/01.RES.86.9.e85, 10807876.
5. Cai H. Hydrogen peroxide regulation of endothelial function: origins, mechanisms, and consequences. Cardiovasc Res 2005, 68:26-36. 10.1016/j.cardiores.2005.06.021, 16009356.
6. San Martin A, Du P, Dikalova A, Lassegue B, Aleman M, Gongora MC, Brown K, Joseph G, Harrison DG, Taylor WR. Reactive oxygen species-selective regulation of aortic inflammatory gene expression in Type 2 diabetes. Am J Physiol Heart Circ Physiol 2007, 292:H2073-H2082. 10.1152/ajpheart.00943.2006, 17237245.
7. Alom-Ruiz SP, Anilkumar N, Shah AM. Reactive oxygen species and endothelial activation. Antioxid Redox Signal 2008, 10:1089-1100. 10.1089/ars.2007.2007, 18315494.
8. Wolin MS. Reactive oxygen species and the control of vascular function. Am J Physiol Heart Circ Physiol 2009, 296:H539-H549. 10.1152/ajpheart.01167.2008, 2660242, 19151250.
9. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007, 39:44-84. 10.1016/j.biocel.2006.07.001, 16978905.
10. Betteridge DJ. What is oxidative stress?. Metabolism 2000, 49:3-8.
11. Droge W. Free radicals in the physiological control of cell function. Physiol Rev 2002, 82:47-95.
12. Jones DP. Radical-free biology of oxidative stress. Am J Physiol Cell Physiol 2008, 295:C849-C868. 10.1152/ajpcell.00283.2008, 2575825, 18684987.
13. D'Autreaux B, Toledano MB. ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nat Rev Mol Cell Biol 2007, 8:813-824. 10.1038/nrm2256, 17848967.
14. Fearon IM, Faux SP. Oxidative stress and cardiovascular disease: novel tools give (free) radical insight. J Mol Cell Cardiol 2009, 47:372-381. 10.1016/j.yjmcc.2009.05.013, 19481547.
15. Papaharalambus CA, Griendling KK. Basic mechanisms of oxidative stress and reactive oxygen species in cardiovascular injury. Trends Cardiovasc Med 2007, 17:48-54. 10.1016/j.tcm.2006.11.005, 1934425, 17292046.
16. Griendling KK, Sorescu D, Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 2000, 86:494-501. 10.1161/01.RES.86.5.494, 10720409.
17. Sorescu D, Weiss D, Lassegue B, Clempus RE, Szocs K, Sorescu GP, Valppu L, Quinn MT, Lambeth JD, Vega JD. Superoxide production and expression of nox family proteins in human atherosclerosis. Circulation 2002, 105:1429-1435. 10.1161/01.CIR.0000012917.74432.66, 11914250.
18. Cave AC, Brewer AC, Narayanapanicker A, Ray R, Grieve DJ, Walker S, Shah AM. NADPH oxidases in cardiovascular health and disease. Antioxid Redox Signal 2006, 8:691-728. 10.1089/ars.2006.8.691, 16771662.
19. Brandes RP, Kreuzer J. Vascular NADPH oxidases: molecular mechanisms of activation. Cardiovasc Res 2005, 65:16-27. 10.1016/j.cardiores.2004.08.007, 15621030.
20. Lassegue B, Clempus RE. Vascular NAD(P)H oxidases: specific features, expression, and regulation. Am J Physiol Regul Integr Comp Physiol 2003, 285:R277-R297.
21. Cai H. NAD(P)H oxidase-dependent self-propagation of hydrogen peroxide and vascular disease. Circ Res 2005, 96:818-822. 10.1161/01.RES.0000163631.07205.fb, 15860762.
22. Mueller CF, Laude K, McNally JS, Harrison DG. ATVB in focus: redox mechanisms in blood vessels. Arterioscler Thromb Vasc Biol 2005, 25:274-278.
23. Babior BM. NADPH oxidase: an update. Blood 1999, 93:1464-1476.
24. Lassegue B, Griendling KK. NADPH oxidases: functions and pathologies in the vasculature. Arterioscler Thromb Vasc Biol 2010, 30:653-661. 10.1161/ATVBAHA.108.181610, 2841695, 19910640.
25. Hilenski LL, Clempus RE, Quinn MT, Lambeth JD, Griendling KK. Distinct subcellular localizations of Nox1 and Nox4 in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2004, 24:677-683. 10.1161/01.ATV.0000112024.13727.2c, 14670934.
26. Dikalov SI, Dikalova AE, Bikineyeva AT, Schmidt HHHW, Harrison DG, Griendling KK. Distinct roles of Nox1 and Nox4 in basal and angiotensin II-stimulated superoxide and hydrogen peroxide production. Free Radical Bio Med 2008, 45:1340-1351.
27. Seshiah PN, Weber DS, Rocic P, Valppu L, Taniyama Y, Griendling KK. Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators. Circ Res 2002, 91:406-413. 10.1161/01.RES.0000033523.08033.16, 12215489.
28. Lassegue B, Sorescu D, Szocs K, Yin Q, Akers M, Zhang Y, Grant SL, Lambeth JD, Griendling KK. Novel gp91(phox) homologues in vascular smooth muscle cells: nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. Circ Res 2001, 88:888-894. 10.1161/hh0901.090299, 11348997.
29. Dikalova A, Clempus R, Lassegue B, Cheng G, McCoy J, Dikalov S, San Martin A, Lyle A, Weber DS, Weiss D. Nox1 overexpression potentiates angiotensin II-induced hypertension and vascular smooth muscle hypertrophy in transgenic mice. Circulation 2005, 112:2668-2676. 10.1161/CIRCULATIONAHA.105.538934, 16230485.
30. Lee MY, San Martin A, Mehta PK, Dikalova AE, Garrido AM, Datla SR, Lyons E, Krause KH, Banfi B, Lambeth JD. Mechanisms of vascular smooth muscle NADPH oxidase 1 (Nox1) contribution to injury-induced neointimal formation. Arterioscler Thromb Vasc Biol 2009, 29:480-487. 10.1161/ATVBAHA.108.181925, 2734189, 19150879.
31. Schroder K, Helmcke I, Palfi K, Krause KH, Busse R, Brandes RP. Nox1 mediates basic fibroblast growth factor-induced migration of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2007, 27:1736-1743. 10.1161/ATVBAHA.107.142117, 17541028.
32. Jo H, Song H, Mowbray A. Role of NADPH oxidases in disturbed flow- and BMP4- induced inflammation and atherosclerosis. Antioxid Redox Signal 2006, 8:1609-1619. 10.1089/ars.2006.8.1609, 16987015.
33. Brown DI, Griendling KK. Nox proteins in signal transduction. Free Radic Biol Med 2009, 47:1239-1253. 10.1016/j.freeradbiomed.2009.07.023, 2763943, 19628035.
34. Yin W, Jo H, Voit EO. Systems analysis of the role of bone morphogenic protein 4 in endothelial inflammation. Ann Biomed Eng 2010, 38:291-307. 10.1007/s10439-009-9822-y, 19851868.
35. Miyano K, Ueno N, Takeya R, Sumimoto H. Direct involvement of the small GTPase Rac in activation of the superoxide-producing NADPH oxidase Nox1. J Biol Chem 2006, 281:21857-21868. 10.1074/jbc.M513665200, 16762923.
36. Takeya R, Ueno N, Kami K, Taura M, Kohjima M, Izaki T, Nunoi H, Sumimoto H. Novel human homologues of p47phox and p67phox participate in activation of superoxide-producing NADPH oxidases. J Biol Chem 2003, 278:25234-25246. 10.1074/jbc.M212856200, 12716910.
37. Banfi B, Clark RA, Steger K, Krause KH. Two novel proteins activate superoxide generation by the NADPH oxidase NOX1. J Biol Chem 2003, 278:3510-3513. 10.1074/jbc.C200613200, 12473664.
38. Lassegue B, Griendling KK. Nox is playing with a full deck in vascular smooth muscle, a commentary on "Noxa1 is a central component of the smooth muscle NADPH oxidase in mice". Free Radic Biol Med 2006, 41:185-187. 10.1016/j.freeradbiomed.2006.04.024, 16814096.
39. Ambasta RK, Schreiber JG, Janiszewski M, Busse R, Brandes RP. Noxa1 is a central component of the smooth muscle NADPH oxidase in mice. Free Radic Biol Med 2006, 41:193-201. 10.1016/j.freeradbiomed.2005.12.035, 16814099.
40. Niu XL, Madamanchi NR, Vendrov AE, Tchivilev I, Rojas M, Madamanchi C, Brandes RP, Krause KH, Humphries J, Smith A. Nox activator 1: a potential target for modulation of vascular reactive oxygen species in atherosclerotic arteries. Circulation 2010, 121:549-559. 10.1161/CIRCULATIONAHA.109.908319, 2843418, 20083677.
41. Touyz RM, Yao G, Quinn MT, Pagano PJ, Schiffrin EL. p47phox associates with the cytoskeleton through cortactin in human vascular smooth muscle cells: role in NAD(P)H oxidase regulation by angiotensin II. Arterioscler Thromb Vasc Biol 2005, 25:512-518. 10.1161/01.ATV.0000154141.66879.98, 15618548.
42. Moskwa P, Dagher MC, Paclet MH, Morel F, Ligeti E. Participation of Rac GTPase activating proteins in the deactivation of the phagocytic NADPH oxidase. Biochemistry 2002, 41:10710-10716. 10.1021/bi0257033, 12186557.
43. Decoursey TE, Ligeti E. Regulation and termination of NADPH oxidase activity. Cell Mol Life Sci 2005, 62:2173-2193. 10.1007/s00018-005-5177-1, 16132232.
44. Kroviarski Y, Debbabi M, Bachoual R, Perianin A, Gougerot-Pocidalo MA, El-Benna J, Dang PM. Phosphorylation of NADPH oxidase activator 1 (NOXA1) on serine 282 by MAP kinases and on serine 172 by protein kinase C and protein kinase A prevents NOX1 hyperactivation. FASEB J 2010, 24:2077-2092. 10.1096/fj.09-147629, 20110267.
45. Savageau MA. A theory of alternative designs for biochemical control systems. Biomedica biochimica acta 1985, 44:875-880.
46. Touyz RM, Schiffrin EL. Ang II-stimulated superoxide production is mediated via phospholipase D in human vascular smooth muscle cells. Hypertension 1999, 34:976-982. 10.1161/01.HYP.34.4.976, 10523394.
47. Touyz RM, Yao G, Schiffrin EL. c-Src induces phosphorylation and translocation of p47phox: role in superoxide generation by angiotensin II in human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2003, 23:981-987. 10.1161/01.ATV.0000069236.27911.68, 12663375.
48. Bokoch GM, Diebold BA. Current molecular models for NADPH oxidase regulation by Rac GTPase. Blood 2002, 100:2692-2696. 10.1182/blood-2002-04-1149, 12351373.
49. Lyle AN, Griendling KK. Modulation of vascular smooth muscle signaling by reactive oxygen species. Physiology (Bethesda) 2006, 21:269-280.
50. Ambasta RK, Kumar P, Griendling KK, Schmidt HH, Busse R, Brandes RP. Direct interaction of the novel Nox proteins with p22phox is required for the formation of a functionally active NADPH oxidase. J Biol Chem 2004, 279:45935-45941. 10.1074/jbc.M406486200, 15322091.
51. Helmcke I, Heumuller S, Tikkanen R, Schroder K, Brandes RP. Identification of structural elements in Nox1 and Nox4 controlling localization and activity. Antioxid Redox Signal 2009, 11:1279-1287. 10.1089/ars.2008.2383, 19061439.
52. Miller FJ, Filali M, Huss GJ, Stanic B, Chamseddine A, Barna TJ, Lamb FS. Cytokine activation of nuclear factor kappa B in vascular smooth muscle cells requires signaling endosomes containing Nox1 and ClC-3. Circ Res 2007, 101:663-671. 10.1161/CIRCRESAHA.107.151076, 17673675.
53. Hanna IR, Hilenski LL, Dikalova A, Taniyama Y, Dikalov S, Lyle A, Quinn MT, Lassegue B, Griendling KK. Functional association of nox1 with p22phox in vascular smooth muscle cells. Free Radic Biol Med 2004, 37:1542-1549. 10.1016/j.freeradbiomed.2004.08.011, 15477006.
54. Cheng G, Diebold BA, Hughes Y, Lambeth JD. Nox1-dependent reactive oxygen generation is regulated by Rac1. J Biol Chem 2006, 281:17718-17726. 10.1074/jbc.M512751200, 16636067.
55. Hassanain HH, Gregg D, Marcelo ML, Zweier JL, Souza HP, Selvakumar B, Ma Q, Moustafa-Bayoumi M, Binkley PF, Flavahan NA. Hypertension caused by transgenic overexpression of Rac1. Antioxid Redox Signal 2007, 9:91-100. 10.1089/ars.2007.9.91, 17115888.
56. Sumimoto H, Miyano K, Takeya R. Molecular composition and regulation of the Nox family NAD(P)H oxidases. Biochem Biophys Res Commun 2005, 338:677-686. 10.1016/j.bbrc.2005.08.210, 16157295.
57. Touyz RM, Chen X, Tabet F, Yao G, He G, Quinn MT, Pagano PJ, Schiffrin EL. Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries: regulation by angiotensin II. Circ Res 2002, 90:1205-1213. 10.1161/01.RES.0000020404.01971.2F, 12065324.
58. Karathanassis D, Stahelin RV, Bravo J, Perisic O, Pacold CM, Cho W, Williams RL. Binding of the PX domain of p47(phox) to phosphatidylinositol 3,4-bisphosphate and phosphatidic acid is masked by an intramolecular interaction. EMBO J 2002, 21:5057-5068. 10.1093/emboj/cdf519, 129041, 12356722.
59. Zafari AM, Ushio-Fukai M, Minieri CA, Akers M, Lassegue B, Griendling KK. Arachidonic acid metabolites mediate angiotensin II-induced NADH/NADPH oxidase activity and hypertrophy in vascular smooth muscle cells. Antioxid Redox Signal 1999, 1:167-179. 10.1089/ars.1999.1.2-167, 11228745.
60. Kim JS, Diebold BA, Babior BM, Knaus UG, Bokoch GM. Regulation of Nox1 activity via protein kinase A-mediated phosphorylation of NoxA1 and 14-3-3 binding. J Biol Chem 2007, 282:34787-34800. 10.1074/jbc.M704754200, 17913709.
61. Voit EO. A First Course in Systems Biology 2012, New York, NY: Garland Science.
62. Chou IC, Voit EO. Recent developments in parameter estimation and structure identification of biochemical and genomic systems. Math Biosci 2009, 219:57-83. 10.1016/j.mbs.2009.03.002, 2693292, 19327372.